
Ectopic Pregnancy — Diagnosis, Treatment & Follow-up
An ectopic pregnancy implants outside the endometrial cavity — about 95–97% in the fallopian tube (mostly the ampulla); incidence is about 1–2% of pregnancies (1–3% in the Indian guideline)
It remains a leading cause of first-trimester maternal death; the classic triad is amenorrhoea, pain, and vaginal bleeding, but many women have no risk factor
Diagnosis rests on a transvaginal ultrasound (TVS) and serial serum ╬▓-hCG (human chorionic gonadotropin)
Treatment is expectant, medical (methotrexate), or surgical, chosen by stability, hCG level, mass size, fetal heart activity, and follow-up reliability
Previous ectopic (recurrence 10–15%) or tubal surgery or sterilisation failure
Pelvic inflammatory disease, Chlamydia, or tuberculosis
Intrauterine device in place or progestogen-only pill (if pregnancy occurs, a higher share are ectopic)
Infertility, assisted reproduction, or ovulation induction
Smoking, age over 35, endometriosis, previous pelvic surgery
Amenorrhoea of 6–8 weeks, then lower abdominal pain
Light, dark-brown vaginal bleeding (often not heavy)
Dizziness, shoulder-tip pain, or pain on defecation (blood in the pouch)
Tender adnexa or cervical motion tenderness; uterus often smaller than dates
Up to half have no risk factor; some are asymptomatic
| Finding | Meaning | Next step |
|---|---|---|
| Intrauterine sac with yolk sac or embryo | Intrauterine pregnancy (heterotopic is rare, but think of it after assisted reproduction) | Routine care |
| Adnexal mass or 'tubal ring' with or without fetal heart | Ectopic pregnancy | Choose treatment by criteria |
| Empty uterus, hCG above the discriminatory level (about 3,500 mIU/mL by the conservative US standard; 1,500 is older practice) | Ectopic or failed pregnancy until proven otherwise | Repeat scan; consider repeat hCG; do not assume miscarriage |
| Empty uterus, hCG below the discriminatory level | PUL | Repeat hCG at 48 hours; scan again; safety-net advice |
| Free fluid with echoes (haemoperitoneum) | Likely rupture | Emergency surgery if unstable |
| hCG change over 48 hours | Interpretation |
|---|---|
| Rise of at least 49% (starting below 1,500), 40% (1,500–3,000), or 33% (above 3,000) | Consistent with a viable intrauterine pregnancy (but about 20% of ectopics can rise normally) |
| Fall of 21–35% or more (depends on starting level) | Likely a failing pregnancy; keep following until negative |
| Plateau, or abnormal rise or fall | Ectopic pregnancy or abnormal intrauterine; repeat scan and plan treatment |
| Topic | What the guideline says |
|---|---|
| Definition and risks | Implantation outside the uterine cavity, 1–3% of pregnancies; PID, endometriosis, IUCD, progestogen-only pill, tubal surgery or ligation, ovulation induction or assisted reproduction |
| Diagnosis | Pregnancy test; abdominal or vaginal ultrasound (empty uterus, pseudosac, adnexal mass, fluid in the pouch); culdocentesis if no ultrasound; blood group and cross-match; histopathology |
| Expectant management | Stable, ultrasound-diagnosed, hCG falling and below 1,000 IU/L; hCG twice weekly, weekly transvaginal scan, until hCG below 20 IU/L; if it plateaus or rises, switch to active treatment |
| Methotrexate eligibility | Stable, unruptured; absolute contraindications: breastfeeding, immunodeficiency, alcoholism, blood dyscrasia, active lung disease, peptic ulcer, liver, kidney or blood disease; relative: sac over 3.5 cm, fetal cardiac activity |
| Methotrexate dose | 1 mg/kg or 50 mg/m² IM with leucovorin 0.1 mg/kg IM; hCG on days 4 and 7; another dose if hCG has not fallen by more than 15%; maximum 4 doses |
| Surgery | Ruptured ectopic: laparotomy to control bleeding and remove the tube; laparoscopic salpingostomy or salpingectomy where skilled; surgery if medical treatment fails |
| Anti-D | Give if the woman is Rh-negative and the partner Rh-positive |
| Referral | Secondary level: no serial hCG or medical care, no laparoscopy, heterotopic pregnancy to be continued, or transfusion needed. Super-specialty: major comorbidity, lack of skills, or assisted-reproduction heterotopic pregnancy |
| Option | Suitable when | Key points |
|---|---|---|
| Expectant | Stable, minimal symptoms; hCG under 1,000–1,500 and falling; no fetal heart; reliable follow-up | hCG every 48 hours, then weekly until negative; about 70% resolve; rupture risk remains |
| Medical (methotrexate) | Stable, unruptured; hCG under 5,000 (best results); mass under 3.5–4 cm; no fetal heart (or low hCG); no intrauterine pregnancy; normal blood count, liver and renal tests | Single dose 50 mg/m² IM on day 1; hCG on days 4 and 7; fall of 15% or more → weekly hCG to negative; less → second dose; success about 70–90% |
| Surgical | Unstable or rupture; significant pain; free fluid; hCG over 5,000–10,000; fetal heart; failed medical care; unable to follow up | Laparoscopic salpingectomy if the other tube is healthy; salpingostomy if the other tube is damaged and fertility is wanted (risk of persistent trophoblast, 5–15%: check hCG weekly) |
| Topic | Advice |
|---|---|
| Before the dose | Full blood count, liver and kidney tests, blood group; exclude intrauterine pregnancy; confirm reliable follow-up for 4–6 weeks |
| Do not give if | Breastfeeding, immunodeficiency, liver, kidney or marrow disease, peptic ulcer, active lung disease, or hypersensitivity |
| Regimens | Single-dose (50 mg/m²) is standard; two-dose (days 1 and 4) for higher hCG; multi-dose with leucovorin is older practice |
| During treatment | Avoid NSAIDs, alcohol, folic acid supplements, sun exposure, and intercourse; pain for 2–3 days is common ('separation pain') |
| Return at once if | Severe pain, dizziness, collapse, heavy bleeding, or shoulder-tip pain |
| Afterwards | Avoid pregnancy for 3 months; hCG until negative; folic acid is restarted |
| Situation | Management |
|---|---|
| Unstable woman | Resuscitation and immediate laparoscopy or laparotomy; clamp the tube and control bleeding |
| Salpingectomy | Preferred when the contralateral tube looks normal; lower recurrence and no persistent trophoblast |
| Salpingostomy | For damaged contralateral tube and wish for fertility; follow hCG weekly; give methotrexate if it plateaus |
| Interstitial (cornual) | High rupture risk and heavy bleeding; methotrexate, cornual resection, or hysteroscopic or laparoscopic surgery by a specialist |
| Caesarean scar pregnancy | Dangerous; refer to a specialist; methotrexate, uterine artery embolisation, or local surgery; avoid curettage |
| Cervical, ovarian, abdominal | Specialist care with bleeding-control plan; abdominal pregnancy may need laparotomy |
| Heterotopic pregnancy | Intrauterine and ectopic together (rare, common after assisted reproduction); surgery if the intrauterine pregnancy is wanted — no methotrexate |
Rh-negative women: give anti-D immunoglobulin (about 250 IU / 50 micrograms within 72 hours); the national guideline gives it when the partner is Rh-positive
Follow-up hCG weekly until negative (the Indian guideline uses below 20 IU/L); rising hCG means persistent trophoblast
Recurrence risk is 10–15% after one ectopic and higher after two; offer early scan at 5–6 weeks in every later pregnancy
Contraception for 3 months after methotrexate; advise on smoking cessation and screening for Chlamydia
Emotional support: offer counselling and a follow-up visit; fertility advice if there is tubal damage
Women with an IUD: if the test is positive, exclude ectopic first
Assuming 'threatened miscarriage' without excluding ectopic, especially with no products of conception passed
Giving reassurance on a single hCG value or a 'normal' rise — about 1 in 5 ectopic pregnancies rise normally
Using methotrexate without a clear diagnosis or without checking the blood, liver and kidney tests
Omitting anti-D and safety-net advice, or losing patients with a PUL
Delaying surgery in an unstable woman because the hCG or ultrasound is not yet available

No comments:
Post a Comment